- Stocks
- Diversified
- Saakshi Medtech
Saakshi Medtech share price
NSE: SAAKSHIDiversified
Saakshi Medtech at a glance
Saakshi Medtech (NSE: SAAKSHI) closed at ₹377.00 on 16 Oct 2026. With a market capitalisation of ₹666 Cr, it ranks 1659th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Diversified sector.
Its return on equity was 4.8% in FY25. Over the past year the share price has risen 121.4%. Its 52-week range is ₹147.40 (27 Oct 2025) to ₹381.45 (23 Sep 2026); the last close is 1.2% below the high. Promoters held 74.82% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹666 CrRank 1659 on NSE
- Price to book
- 2.31×FY25
- ROE
- 4.8%FY25
- ROCE
- 6.2%FY25
- Debt to equity
- 0.18FY25
- Net profit margin
- 5.1%FY25
- Book value / share
- ₹55.53FY25
- 52-week high
- ₹381.4523 Sep 2026
- 52-week low
- ₹147.4027 Oct 2025
- 1-year return
- +121.4%
- RSI (14-day)
- 63.9
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.11% | +5.3% | +0.8% | +27.8% | +121.4% |
Saakshi Medtech financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | ₹60 Cr | ₹92 Cr | ₹122 Cr | ₹122 Cr | ₹92 Cr |
| Operating profit | ₹3 Cr | ₹13 Cr | ₹17 Cr | ₹15 Cr | ₹7 Cr |
| Net profit | ₹2 Cr | ₹9 Cr | ₹12 Cr | ₹11 Cr | ₹5 Cr |
| EPS (₹) | ₹80.96 | ₹358.54 | ₹9.52 | ₹6.40 | ₹2.67 |
| Cash from operations | ₹0 Cr | ₹11 Cr | ₹11 Cr | ₹7 Cr | ₹3 Cr |
| Total debt | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹15 Cr | ₹14 Cr |
| Shareholders' equity | ₹20 Cr | ₹29 Cr | ₹42 Cr | ₹93 Cr | ₹98 Cr |
Saakshi Medtech shareholding pattern
| Holder | 30 Sep 2024 | 31 Dec 2024 | 31 Mar 2025 | 30 Sep 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.63% | 73.63% | 73.63% | 73.89% | 74.82% | 74.82% |
| Foreign institutions | 0.11% | 0.10% | 0.10% | 0.19% | 0.07% | 0.07% |
| Domestic institutions | 1.54% | 1.51% | 1.59% | 1.32% | 0.30% | 0.27% |
| Non-institutions | 24.73% | 24.76% | 24.69% | 24.60% | 24.81% | 24.84% |
Saakshi Medtech vs peers
The listed Diversified companies nearest to Saakshi Medtech by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| SAAKSHISaakshi Medtech | ₹377.00 | −0.11% | +121.4% | ₹666 Cr | — | — |
| GFLLIMITEDGFL | ₹58.00 | −4.92% | −5.4% | ₹637 Cr | — | — |
| STCINDIASTC India | ₹104.00 | −1.52% | −23.6% | ₹624 Cr | — | — |
| PRAVEGPraveg | ₹231.00 | −0.22% | — | ₹604 Cr | — | — |
| PPLPrakash Pipes | ₹252.00 | −1.10% | −19.5% | ₹603 Cr | — | — |
| SINGERINDSinger India | ₹90.30 | +0.46% | — | ₹562 Cr | — | — |
| APSAPS India | ₹223.50 | −5.70% | −53.1% | ₹451 Cr | — | — |
Ask anything about Saakshi Medtech
Pivot answers on the live chart with evidence you can check, and tests strategies against SAAKSHI's own history. Try: “Why has SAAKSHI moved over the last three months?” · “Backtest a 50-day moving-average crossover on SAAKSHI over five years” · “Compare SAAKSHI with GFLLIMITED on margins and valuation”
Frequently asked questions about Saakshi Medtech
What is the share price of Saakshi Medtech today?
Saakshi Medtech (NSE: SAAKSHI) last closed at ₹377.00 on 16 Oct 2026. Its 52-week high is ₹381.45 and its 52-week low is ₹147.40.
What is the market cap of Saakshi Medtech?
Saakshi Medtech's market capitalisation is ₹666 Cr (₹666 Cr) at the 19 Oct 2026 close, ranking 1659th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Saakshi Medtech?
Return on equity was 4.8% in FY25 and return on capital employed was 6.2% in FY25 (standalone figures).
Is Saakshi Medtech a debt-free company?
No. Saakshi Medtech's debt-to-equity ratio was 0.18 in FY25, with total debt of ₹14 Cr.
How has Saakshi Medtech stock performed over the last year?
Saakshi Medtech's share price has risen 121.4% over the past year, +27.8% over three months and +0.8% over one month, to the 19 Oct 2026 close.
What is the shareholding pattern of Saakshi Medtech?
As of 30 Jun 2026: promoters 74.82%, foreign institutions 0.07%, domestic institutions 0.27%, non-institutions 24.84%.
Who are Saakshi Medtech's competitors?
The listed Diversified companies closest to Saakshi Medtech by market cap are GFL, STC India, Praveg, Prakash Pipes, Singer India and APS India.
Is Saakshi Medtech a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Saakshi Medtech's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SAAKSHI against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 16 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Diversified stocks · companies starting with S · all NSE stocks · this page as text